Interim Consolidated Statements of Operations (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Income Statement [Abstract]
Research and development	$ 1,119	$ 691
General and administrative	1,273	1,472
Operating loss	(2,392)	(2,163)
Financing income (expenses), net	4	(42)
Net loss	$ (2,388)	$ (2,205)
Basic and diluted net loss per share	$ (0.34)	$ (0.31)
Basic and diluted weighted average common shares outstanding	7,108,133	7,154,245